March was Multiple Myeloma Awareness Month. In this short video, Cristina João, Haemato-oncologist of the Haemato-oncology Unit at the Champalimaud Foundation, explains what this pathology is and talks about the activities that the Unit has developed for improving the care of people with Multiple Myeloma. She also points out that, in addition to clinical activity, the Haemato-Oncology Unit does translational research through the Foundation's Lymphoma and Myeloma Research Group, which she leads.

Neste último vídeo da série, Laura Fernández, Cirurgiã Colorretal, fala da investigação da equipa sobre o Protocolo Watch&Wait (W&W).

Em estudos recentes, mostraram que a probabilidade de os doentes com cancro retal, que permanecem livres de tumores durante cinco anos, voltarem a desenvolver a doença é quase nula. Atualmente, a equipa está a tentar determinar quais os doentes, integrados no programa W&W, que serão mais susceptíveis de apresentar metástases.

On behalf of the International Cancer Imaging Society (ICIS) and the Champalimaud Foundation, we would like to invite you to register for our jointly hosted meeting 'AI and Machine Learning in Cancer Imaging 3.0', which will be held on 30 June and 1 July 2023.  The meeting will take place at the Champalimaud Centre for the Unknown, in Lisbon. 

In Portugal, the winning scientists are Isabel Gordo (Gulbenkian Institute of Science, IGC), Maria Manuel Mota (João Lobo Antunes Institute of Molecular Medicine, iMM), Mariana Pinho (ITQB-NOVA) and Henrique Veiga-Fernandes (Champalimaud Foundation). Each will receive between €2.5M and €3.5M for the development of research projects over the next five years.

Modern scientific endeavours are often guided by the positivistic ideal of obtaining a neutral, detached point of observation from which truths about the world can be deduced and believed to hold independently of the socio-political context in which they were obtained.

There are different ways to classify cancers: for instance, by the organ (or tissue) in which they originate, and by the type of cells they involve. Cancers can be solid (tumour-forming) or liquid (blood cancers).

Using the first method yields more than 200 different types of cancer. In alphabetical order, the most common are: bladder cancer, breast cancer, colon and rectal cancer, endometrial cancer, kidney cancer, leukemia (blood cancer), liver cancer, lung cancer melanoma (skin cancer), non-Hodgkin lymphoma, pancreatic cancer, prostate cancer, and thyroid cancer.